Lung Cancer Clinical Trial
Official title:
4D Cone Beam CT Reconstruction for Radiotherapy Via Motion Vector Optimization
To validate a new 4D Cone Beam CT (4DCBCT) reconstruction algorithm that was developed in our research group recently in terms of its geometry and intensity accuracy through real patient studies. Dose calculation found out in this study will not be used on the subject
Before patient studies, we will have conducted experimental studies on a lung phantom.
The purpose of this step is to comprehensively evaluate the system performance and gain
confidence prior to its applications to real patient cases. We will operate the phantom to
simulate motion patterns with different motion amplitude/frequency. 4DCBCT images will be
reconstructed using our method and the conventional FDK algorithm. The validation will focus
on two aspects: HU value accuracy and anatomy location accuracy.
Imaging dose in these scans will be also measured in phantom studies to make sure the
radiation dose level is acceptable for patient studies. adiation dose level is acceptable for
patient studies.
After testing the reconstruction algorithm on phantoms, we will move on to real patient
cases. We will conduct patient studies on lung cancer patients treated under Image Guided
Radiation Therapy (IGRT) at Department of Radiation Oncology, UT Southwestern Medical Center.
CBCT projection data will be collected (4 gantry rotations, each within 1 minute) in only one
treatment fraction. 4DCBCT images will be reconstructed from the current standard FDK
algorithm using all the projection data, and from our system using data only in the first
gantry rotation. Patient 4DCT image will also be used, which have been acquired during
treatment planning stage per standard treatment protocol at UTSW.
The image quality of our 4DCBCT will be assessed in two aspects:
1) geometry accuracy, by comparing selected anatomical landmark locations with those in
4DCBCT reconstructed by the FDK algorithm. 2) HU accuracy, by comparing HU values in selected
regions of interest (ROIs) with those in 4DCT.
The 4DCT images will be extracted from radiation therapy information system MOSAIQ.
The CBCT projection data will be exported from a computer that controls the image acquisition
system
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|